| Source: |
| Type: pro-apoptotic protein |
| Bid is an abundant pro-apoptotic protein of the Bcl-2 family that is crucial for death receptor-mediated apoptosis in many cell systems. The expression of BID can serve as a prognostic marker in several cancers. Higher levels of BID are often associated with increased apoptosis and better treatment responses, while lower levels may indicate resistance to therapy and poorer outcomes. Generation of Truncated Bid (tBid): • When apoptosis is signaled, specific proteases (such as caspase-8) cleave full-length Bid into its truncated form, tBid. • tBid is the active form that translocates to mitochondria. So "the truncation of Bid" means that the protein has been converted into an active form (tBid) that supports apoptosis. |
| Melanoma is a rare form of skin cancer. It is more likely to invade nearby tissues and spread to other parts of the body than other types of skin cancer. |
| 5556- | BBM, | Berbamine, a novel nuclear factor κB inhibitor, inhibits growth and induces apoptosis in human myeloma cells |
| - | in-vitro, | Melanoma, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:39 Cells:% prod#:% Target#:466 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid